Viewing Study NCT05036408



Ignite Creation Date: 2024-05-06 @ 4:37 PM
Last Modification Date: 2024-10-26 @ 2:13 PM
Study NCT ID: NCT05036408
Status: COMPLETED
Last Update Posted: 2024-05-29
First Post: 2021-07-01

Brief Title: Cancer Pain Rehabilitation Program to Reduce Pain Related Distress and Reliance of Pain Medication Through Multimodal Nonpharmacological Solutions
Sponsor: City of Hope Medical Center
Organization: City of Hope Medical Center

Study Overview

Official Title: Cancer Pain Rehabilitation Program in Cancer Survivorship Feasibility Study
Status: COMPLETED
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This clinical trial studies the effect of an interdisciplinary program with strong patient involvement on managing long-term chronic pain for cancer survivors The purpose of this study is to determine whether enrolling patients into an interdisciplinary program can improve mobility with physical and occupational therapy and participation in online group psychotherapy that teaches coping skills to enhance quality of life
Detailed Description: PRIMARY OBJECTIVE

I To test the feasibility of an interdisciplinary functional restoration program in cancer survivors with chronic pain and restoring physical function

EXPLORATORY OBJECTIVE

I To explore the preliminary effect of functional restoration program FRP in restoring physical function and reducing pain which ultimately decreases opioid consumption

OUTLINE

Patients participate in the cancer pain rehabilitation program for 6 weeks including educational sessions over 2 hours once weekly group psychological interventions group physical therapy and 11 physical and occupational therapy treatment per the patients treatment plan Patients may also undergo osteopathic manual treatments per physical and occupational therapy assessments

After completion of study intervention patients are followed up at 3 months

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
NCI-2021-02052 REGISTRY None None
19530 OTHER None None
P30CA033572 NIH City of Hope Comprehensive Cancer Center httpsreporternihgovquickSearchP30CA033572